This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Public ClinicalTrials.gov record NCT00996489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post-approval of Coaptite® in the Treatment of Female Urinary Incontinence
Study identification
- NCT ID
- NCT00996489
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Merz North America, Inc.
- Industry
- Enrollment
- 459 participants
Conditions and interventions
Interventions
- Coaptite® Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2008
- Primary completion
- Oct 25, 2015
- Completion
- Nov 1, 2015
- Last update posted
- Jul 22, 2019
2008 – 2015
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Wetumpka | Alabama | — | — |
| Not listed | Surprise | Arizona | — | — |
| Not listed | Encinitas | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Templeton | California | — | — |
| Not listed | Celebration | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Berwyn | Illinois | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Akron | Ohio | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Temple | Texas | — | — |
| Not listed | Mountlake Terrace | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00996489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00996489 live on ClinicalTrials.gov.